Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Rebuilding Joint Surface to Prevent Pain and Immobility

Project description

Rebuilding damaged cartilage for pain-free joints

Cartilage tissue is necessary for pain-free movement of joints. This thin layer of highly specialised tissue covers the end of bones in the joints where it functions as a load absorbing cushion with invincible lubrication properties. Unfortunately, cartilage has limited self-renewal capacity because of the lack of vessels and nerves spanning the tissue. Therefore, cartilage damage due to trauma or osteoarthritis cannot be inherently healed but must be repaired surgically. The EIC-funded RePace project has developed an innovative implant that facilitates quick rehabilitation and restores the original functionality of the tissue. The generated implant consists of a biodegradable matrix that provides mechanical support for fast rehabilitation back to pain-free activity alongside long-term results and quality of life improvement.

Objective

A healthy layer of articular cartilage at the end of bones in joints is essential for painless movement. When cartilage is damaged, it has minimal innate regenerative properties and there is no effective medical cure. Cartilage damage seriously reduce quality of life and has severe economic impact since loss of cartilage leads to osteoarthritis (OA) that causes hundreds of billions of Euros healthcare and related costs annually.

Many attempts have been made to restore joint surface cartilage, but the tissue has shown to be extremely difficult to rebuild.

Askel has developed a unique way to rebuild joint surfaces for pain-free movement. COPLA is a biodegradable implant that creates a weight-adaptive microenvironment in the damaged site enabling quick rehabilitation and cartilage regeneration to prevent OA.

COPLA will become the Gold Standard for early cartilage repair with rapid recovery and long-term results, ensuring pain-free movement, high quality of life and prevention of OA.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2021-ACCELERATOROPEN-01

See all projects funded under this call

Coordinator

ASKEL HEALTHCARE OY
Net EU contribution
€ 2 499 000,00
Address
SILTASAARENKATU 8-10
00530 Helsinki
Finland
SME
Yes
Region
Manner-Suomi Helsinki-Uusimaa Helsinki-Uusimaa
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 3 570 000,00